Feb. 26 at 9:09 PM
$BDSX Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of -
$0.49 up 56.64% YoY
• Reported revenue of
$28.75M up 40.76% YoY
• Biodesix anticipates generating
$106M in total revenue in 2026, representing 23% growth, and expects continued improvement toward sustained Adjusted EBITDA positivity, with gross margin maintained at approximately 80%.
